Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
GenomeScan is a premier Dutch biotechnology company specializing in Next-Generation Sequencing (NGS), microarray technologies, Sanger sequencing, and comprehensive bioinformatics solutions. Catering to academic research, pharmaceutical development, agritech, and clinical diagnostics, GenomeScan provides high-quality genomic data and analysis to accelerate scientific discovery and innovation. They are known for their expertise in handling complex projects and delivering tailored genomic services from their state-of-the-art facility in Leiden, Netherlands.
Serves as the central hub for all operations, including advanced sequencing laboratories, bioinformatics data analysis, research and development, quality assurance, and corporate administration.
Located within the Leiden Bio Science Park, one of Europe's leading science parks. The facility houses state-of-the-art Next-Generation Sequencing equipment and advanced laboratory infrastructure.
A collaborative and innovative environment driven by scientific excellence, fostering teamwork among molecular biologists, bioinformaticians, lab technicians, and support staff. Emphasis on quality, precision, continuous improvement, and customer-focused solutions in a dynamic research-oriented setting.
The Leiden headquarters is strategically positioned to serve the European and global life sciences market. Its advanced facilities and expert team are critical to delivering high-throughput genomic services and contributing to cutting-edge research and diagnostics.
While headquartered and operating its primary laboratories in Leiden, Netherlands, GenomeScan serves a global clientele. This includes academic institutions, pharmaceutical companies, biotechnology firms, and agricultural research organizations across Europe, North America, Asia, and other regions. They support international research projects and clinical studies through their advanced genomic services and bioinformatics expertise, often collaborating with international partners and utilizing sales representatives in key markets to extend their reach.
Plesmanlaan 1d
Leiden
South Holland
The Netherlands
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, GenomeScan' leadership includes:
GenomeScan has been backed by several prominent investors over the years, including:
In the last 12 months (approx. May 2023 - May 2024), GenomeScan has significantly strengthened its executive team with the appointment of a new Chief Operating Officer and a new Chief Financial Officer, positioning the company for further growth and operational excellence. No major executive departures were publicly noted during this period.
Discover the tools GenomeScan uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While GenomeScan's specific email format policy isn't publicly detailed, common formats for European tech and biotech companies include [first_initial][last]@[domain] or [first].[last]@[domain]. Using these patterns can be a reasonable approach for outreach.
[first_initial][last]@genomescan.com or [first].[last]@genomescan.com
Format
jdoe@genomescan.com or jane.doe@genomescan.com
Example
70%
Success rate
GenomeScan Website • February 19, 2024
GenomeScan announced the appointment of Kees van den Berg as its new Chief Financial Officer. He brings a wealth of experience in finance and strategy to support GenomeScan's continued growth and development in the genomics sector....more
GenomeScan Website • January 10, 2024
Dr. Jean-Philippe Wax has been appointed as the new Chief Operating Officer at GenomeScan. His extensive background in life sciences operations is expected to enhance GenomeScan's service delivery and operational excellence....more
GenomeScan Website • October 5, 2023
GenomeScan has partnered with Cyclomics to develop and implement innovative liquid biopsy solutions for cancer diagnostics. This collaboration aims to leverage Cyclomics' novel DNA sequencing technology with GenomeScan’s established NGS expertise to improve cancer detection and monitoring....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including GenomeScan, are just a search away.